Staffing levels changed little across 2020 as M&A slowed – but sales are another story.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
But launch is unlikely before 2024.
The newest player in corporate financing, Intuitive, intends to deploy its fund with surgical precision.
Welcome to the calm before the Covid-19 storm.